These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 28409823)

  • 1. A sphingosine-1-phosphate receptor type 1 agonist, ASP4058, suppresses intracranial aneurysm through promoting endothelial integrity and blocking macrophage transmigration.
    Yamamoto R; Aoki T; Koseki H; Fukuda M; Hirose J; Tsuji K; Takizawa K; Nakamura S; Miyata H; Hamakawa N; Kasuya H; Nozaki K; Hirayama Y; Aramori I; Narumiya S
    Br J Pharmacol; 2017 Jul; 174(13):2085-2101. PubMed ID: 28409823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ASP4058, a novel agonist for sphingosine 1-phosphate receptors 1 and 5, ameliorates rodent experimental autoimmune encephalomyelitis with a favorable safety profile.
    Yamamoto R; Okada Y; Hirose J; Koshika T; Kawato Y; Maeda M; Saito R; Hattori K; Harada H; Nagasaka Y; Morokata T
    PLoS One; 2014; 9(10):e110819. PubMed ID: 25347187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sphingosine-1-phosphate receptor 1/5 selective agonist alleviates ocular vascular pathologies.
    Nakamura S; Yamamoto R; Matsuda T; Yasuda H; Nishinaka A; Takahashi K; Inoue Y; Kuromitsu S; Shimazawa M; Goto M; Narumiya S; Hara H
    Sci Rep; 2024 Apr; 14(1):9700. PubMed ID: 38678148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sphingosine 1-Phosphate Receptor 1 Signaling Maintains Endothelial Cell Barrier Function and Protects Against Immune Complex-Induced Vascular Injury.
    Burg N; Swendeman S; Worgall S; Hla T; Salmon JE
    Arthritis Rheumatol; 2018 Nov; 70(11):1879-1889. PubMed ID: 29781582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sphingosine-1-Phosphate Receptor 1 Activation Enhances Leptomeningeal Collateral Development and Improves Outcome after Stroke in Mice.
    Iwasawa E; Ishibashi S; Suzuki M; Li F; Ichijo M; Miki K; Yokota T
    J Stroke Cerebrovasc Dis; 2018 May; 27(5):1237-1251. PubMed ID: 29337049
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sphingosine-1-phosphate receptor-1 (S1P
    Karuppuchamy T; Behrens EH; González-Cabrera P; Sarkisyan G; Gima L; Boyer JD; Bamias G; Jedlicka P; Veny M; Clark D; Peach R; Scott F; Rosen H; Rivera-Nieves J
    Mucosal Immunol; 2017 Jan; 10(1):162-171. PubMed ID: 27049060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The S1P1 receptor-selective agonist CYM-5442 reduces the severity of acute GVHD by inhibiting macrophage recruitment.
    Cheng Q; Ma S; Lin D; Mei Y; Gong H; Lei L; Chen Y; Zhao Y; Hu B; Wu Y; Yu X; Zhao L; Liu H
    Cell Mol Immunol; 2015 Nov; 12(6):681-91. PubMed ID: 25088224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impaired endothelial barrier function in apolipoprotein M-deficient mice is dependent on sphingosine-1-phosphate receptor 1.
    Christensen PM; Liu CH; Swendeman SL; Obinata H; Qvortrup K; Nielsen LB; Hla T; Di Lorenzo A; Christoffersen C
    FASEB J; 2016 Jun; 30(6):2351-9. PubMed ID: 26956418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sphingosine-1-phosphate agonists increase macrophage homing, lymphocyte contacts, and endothelial junctional complex formation in murine lymph nodes.
    Singer II; Tian M; Wickham LA; Lin J; Matheravidathu SS; Forrest MJ; Mandala S; Quackenbush EJ
    J Immunol; 2005 Dec; 175(11):7151-61. PubMed ID: 16301618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of endothelial nitric oxide synthase activation in endothelial cells by S1P1 and S1P3.
    Tölle M; Klöckl L; Wiedon A; Zidek W; van der Giet M; Schuchardt M
    Biochem Biophys Res Commun; 2016 Aug; 476(4):627-634. PubMed ID: 27282481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sphingosine-1-Phosphate Receptor-1 Agonist Sew2871 Causes Severe Cardiac Side Effects and Does Not Improve Microvascular Barrier Breakdown in Sepsis.
    Flemming S; Burkard N; Meir M; Schick MA; Germer CT; Schlegel N
    Shock; 2018 Jan; 49(1):71-81. PubMed ID: 28538086
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ozanimod (RPC1063) is a potent sphingosine-1-phosphate receptor-1 (S1P1 ) and receptor-5 (S1P5 ) agonist with autoimmune disease-modifying activity.
    Scott FL; Clemons B; Brooks J; Brahmachary E; Powell R; Dedman H; Desale HG; Timony GA; Martinborough E; Rosen H; Roberts E; Boehm MF; Peach RJ
    Br J Pharmacol; 2016 Jun; 173(11):1778-92. PubMed ID: 26990079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of sphingosine kinase-1 reverses the increase in lung vascular permeability through sphingosine-1-phosphate receptor signaling in endothelial cells.
    Tauseef M; Kini V; Knezevic N; Brannan M; Ramchandaran R; Fyrst H; Saba J; Vogel SM; Malik AB; Mehta D
    Circ Res; 2008 Nov; 103(10):1164-72. PubMed ID: 18849324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective effects of sphingosine-1-phosphate receptor agonist treatment after myocardial ischaemia-reperfusion.
    Hofmann U; Burkard N; Vogt C; Thoma A; Frantz S; Ertl G; Ritter O; Bonz A
    Cardiovasc Res; 2009 Jul; 83(2):285-93. PubMed ID: 19416991
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of vascular permeability by the sphingosine-1-phosphate receptor-2 (S1P2R) and its downstream effectors ROCK and PTEN.
    Sanchez T; Skoura A; Wu MT; Casserly B; Harrington EO; Hla T
    Arterioscler Thromb Vasc Biol; 2007 Jun; 27(6):1312-8. PubMed ID: 17431187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sphingosine-1-phosphate receptor 1 transmits estrogens' effects in endothelial cells.
    Sukocheva O; Wadham C; Gamble J; Xia P
    Steroids; 2015 Dec; 104():237-45. PubMed ID: 26476183
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathophysiological Consequences of a Break in S1P1-Dependent Homeostasis of Vascular Permeability Revealed by S1P1 Competitive Antagonism.
    Bigaud M; Dincer Z; Bollbuck B; Dawson J; Beckmann N; Beerli C; Fishli-Cavelti G; Nahler M; Angst D; Janser P; Otto H; Rosner E; Hersperger R; Bruns C; Quancard J
    PLoS One; 2016; 11(12):e0168252. PubMed ID: 28005953
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A sphingosine 1-phosphate 1 receptor agonist modulates brain death-induced neurogenic pulmonary injury.
    Sammani S; Park KS; Zaidi SR; Mathew B; Wang T; Huang Y; Zhou T; Lussier YA; Husain AN; Moreno-Vinasco L; Vigneswaran WT; Garcia JG
    Am J Respir Cell Mol Biol; 2011 Nov; 45(5):1022-7. PubMed ID: 21617203
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Piperazinyl-oxadiazoles as selective sphingosine-1-phosphate receptor agonists.
    Horan JC; Sanyal S; Choi Y; Hill-Drzewi M; Patnaude L; Anderson S; Fogal S; Mao C; Cook BN; Gueneva-Boucheva K; Fisher MB; Hickey E; Pack E; Bannen LC; Chan DS; Mac MB; Ng SM; Wang Y; Xu W; Modis LK; Lemieux RM
    Bioorg Med Chem Lett; 2014 Oct; 24(20):4807-11. PubMed ID: 25241927
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Sphingosine-1 Phosphate receptor agonist FTY720 dose dependently affected endothelial integrity in vitro and aggravated ventilator-induced lung injury in mice.
    Müller HC; Hocke AC; Hellwig K; Gutbier B; Peters H; Schönrock SM; Tschernig T; Schmiedl A; Hippenstiel S; N'Guessan PD; Rosseau S; Suttorp N; Witzenrath M
    Pulm Pharmacol Ther; 2011 Aug; 24(4):377-85. PubMed ID: 21419858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.